Sign up to our newsletter Subscribe
Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?
Precision Medicine and Economics
Precision medicine tailors treatments to the needs of individual patients by considering genetic, environmental and lifestyle factors. They can target the underlying causes of a patient’s condition, improve effectiveness, and reduce side effects.
The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe
Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Therapies
